Alzheimer's & Dementia
Baseline plasma C1q and C3 as potential biomarkers for lecanemab efficacy and ARIA risk in early Alzheimer's disease
Trial in peopleBiomarkers
Papers by Sheng-Min Wang
2 results
- AAIC 2025 Abstract
Diabetes mellitus‐induced differential cerebellar volume reduction across Alzheimer's disease trajectory
Study in peoplePopulations